Abstract: Objective To evaluate the effects of Sorafenib combined with Praziquantel on hepatic fibrosis pathology of mice with
schistosomiasis japonicum. Methods After infected with schistosoma japonicum cercaria percutaneously through the abdomen for
8 weeks, total of 65 mice formed schistosomiasis liver fibrosis model, and were randomly divided into infected group (10 cases),
Sorafenib group (15 cases), Praziquantel group (20 cases) and Sorafenib combined with Praziquantel group (20 cases). Five normal
mice were taken as the control group. Drug treatment was given immediately. Praziquantel group was treated with Praziquantel
150 mg/(kg·d) for 2 days and continued to be given equivalent normal saline solution once a day for 2 weeks. Sorafenib group was
treated with equivalent normal saline solution once a day for 2 days and continued to be treated with Sorafenib 2 mg/(kg·d) once a
day for 2 weeks. Sorafenib combined with Praziquantel group was treated with Praziquantel at the same dose for 2 days followed by
treatment with Sorafenib 2 mg/(kg·d) for 2 weeks. The control group and infected group were treated with equivalent normal saline
solution from the beginning of drug delivery to the end of the experiment. After the mice in each group were sacrificed, the fresh liver
tissues were observed, while parts of the liver were used for HE staining and Masson staining to observe the pathological changes
and fibrosis extent. Image-Pro Plus 6.0 software was applied to calculate collagen fiber relative area quantitatively which showed
fibrosis extent. Results In Sorafenib combined with Praziquantel group, pathological damage of mice liver reduced significantly
and fibrosis extent relieved obviously. There was significant difference when collagen area in Sorafenib combined with Praziquantel
group (1.86 ± 0.87) was compared with that in Praziquantel group (3.78 ± 1.08) and infected group (5.97 ± 1.77) (P < 0.0001). But
the difference was not statistically significant between infected group and Sorafenib group (5.51 ± 1.11) (P = 0.42). Conclusion On
the basis of Praziquantel insecticide, Sorafenib can reduce liver pathological damage in mice with Schistosoma japonicum, and the
effect of Sorafenib combined with Praziquantel on anti-fibrosis is reinforced cooperatively.
|